Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: Possible association with postoperative macular oedema

British Journal of Ophthalmology

Volumn 99, Issue 7, 2015, Pages 960-966

  Yoshida, Shigeo ^a   Kubo, Yuki ^a   Kobayashi, Yoshiyuki ^a   Zhou, Yedi ^a   Nakama, Takahito ^a   Yamaguchi, Muneo ^a   Tachibana, Takashi ^a   Ishikawa, Keijiro ^a   Arita, Ryoichi ^a   Nakao, Shintaro ^a   Sassa, Yukio ^a,b   Oshima, Yuji ^a   Kono, Toshihiro ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka University Chikushi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; LENS IMPLANTATION; MACULAR EDEMA; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; VITRECTOMY; VITREOUS BODY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; VISUAL ACUITY;

CHEMOKINE CCL2; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LENS IMPLANTATION, INTRAOCULAR; MACULAR EDEMA; MALE; MIDDLE AGED; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 84937733986     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-306366     Document Type: Article

References (25)

1. Sivaprasad S, Gupta B, Crosby-Nwaobi R, et al. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57:347-70.
2. Hiscott P, Wong D, Grierson I. Challenges in ophthalmic pathology: the vitreoretinal membrane biopsy. Eye 2000;14(Pt 4):549-59.
3. Elner SG, Elner VM, Jaffe GJ, et al. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995;14:1045-53.
4. Kastelan S, Tomic M, Gverovic Antunica A, et al. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm 2013;2013:213130.
5. Yoshimura T, Sonoda KH, Sugahara M, et al. Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases. PLoS ONE 2009;4:e8158.
6. Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 2009;116:73-9.
7. Owen LA, Hartnett ME. Soluble mediators of diabetic macular edema: the diagnostic role of aqueous VEGF and cytokine levels in diabetic macular edema. Curr Diab Rep 2013;13:476-80.
8. Yoshida A, Yoshida S, Khalil AK, et al. Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. Invest Ophthalmol Vis Sci 1998;39:1097-106.
9. Blankenship GW, Machemer R. Long-term diabetic vitrectomy results. Report of 10 year follow-up. Ophthalmology 1985;92:503-6.
10. Yoshida S, Ishikawa K, Matsumoto T, et al. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:799-804.
11. Yoshida S, Nakama T, Ishikawa K, et al. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2012;53:6997-7003.
12. Yanyali A, Aytug B, Horozoglu F, et al. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol 2007;144:124-6.
13. ETDRS Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991;98:786-806.
14. Yoshida S, Ishikawa K, Asato R, et al. Increased expression of periostin in vitreous and fibrovascular membranes obtained from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2011;52:5670-8.
15. Funk M, Schmidinger G, Maar N, et al. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010;30:1412-19.
16. Sohn HJ, Han DH, Kim IT, et al. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema. Am J Ophthalmol 2011;152:686-94.
17. Shimura M, Nakazawa T, Yasuda K, et al. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Am J Ophthalmol 2008;145:854-61.
18. Kawai M, Inoue T, Inatani M, et al. Elevated levels of monocyte chemoattractant protein-1 in the aqueous humor after phacoemulsification. Invest Ophthalmol Vis Sci 2012;53:7951-60.
19. Yoshida S, Yoshida A, Ishibashi T, et al. Role of MCP-1 and MIP-1alpha in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol 2003;73:137-44.
20. Tesch GH. Role of macrophages in complications of type 2 diabetes. Clin Exp Pharmacol Physiol 2007;34:1016-19.
21. Morescalchi F, Duse S, Gambicorti E, et al. Proliferative vitreoretinopathy after eye injuries: an overexpression of growth factors and cytokines leading to a retinal keloid. Mediators Inflamm 2013;2013:269787.
22. Funatsu H, Yamashita H, Ikeda T, et al. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003;110:1690-6.
23. Roh MI, Kim HS, Song JH, et al. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema. Ophthalmology 2009;116:80-6.
24. Stefansson E. Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 2009;247:147-63.
25. Boyer DS, Faber D, Gupta S, et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915-23.